While stem cells have the most therapeutic potential, the benefits of regenerative medicine may best be mobilised using extracellular vesicles (EVs), also known in the past as “cellular dust”.
A team of researchers from CNRS, AP-HP, INSERM and Paris Descartes and Paris Diderot Universities have tested these vesicles for the first time in a porcine model for the treatment of post-operative digestive fistulas. Their results, which yielded a 100% success rate and appear in the 23 October 2018 edition of ACS Nano, open the door to testing in humans and broader possibilities for applications.
Extracellular vesicles are matter that is released by cells. Seen for many years as not having any value, this ‘cellular dust’ has been studied and presents therapeutic properties similar to their mother cells, without their disadvantages: These vesicles do not divide, limiting the risk of cancer, and do not differentiate either, thus preventing the development of poor function. Furthermore, it appears that they can be produced by a single donor for several patients, and have already demonstrated their therapeutic potential in animals in repairing heart, liver and kidney lesions.
In the case of digestive fistula, in which there is abnormal communication between organs in the digestive tract or with the skin, regenerative medicine is an important therapeutic avenue to explore. Fistulas of this kind respond poorly to current treatments; they can develop following post-operative complications or an auto-immune disorders such as Crohn’s disease, which causes digestive tract dysfunction.
For the first time, scientists at the Matières et systèmes complexes Lab (CNRS/Université Paris Diderot), the Gastroenterology and Endoscopy Department at the Hôpital Européen Georges Pompidou (HEGP) AP-HP and the Laboratoire Imagerie de l’angiogénèse, plateforme d’imagerie du petit animal (INSERM/Université Paris Descartes/HEGP)1, used extracellular vesicles from stem cells to treat digestive fistula in a swine model. The study reveals that local injections into the fistula of a gel containing these vesicles results in the complete closure of post-operative digestive fistula.
Researchers intend to test the new approach in a perineal fistula model found in Crohn’s disease, with the hope of replacing the stem cell injections. The vesicle gel could be administered locally and easily and become a simpler, safer and more effective treatment.
The Latest on: Extracellular vesicles
via Google News
The Latest on: Extracellular vesicles
- Brain Cancer Cell Ingests Extracellular Vesicles (EVs) (image) on December 10, 2018 at 2:25 pm
Brain cancer cell (nucleus in blue) receives messages from two other cells via EVs (in green and red). SIM - Structured illumination microscopy (Zeiss LSM880 ElyraPS1 - Glen cores) Disclaimer: AAAS an... […]
- International Society for Extracellular Vesicles Releases Latest Study to the Members of the EV Field on November 27, 2018 at 6:00 am
MOUNT ROYAL, N.J., Nov. 27, 2018 /PRNewswire-PRWeb/ -- The International Society for Extracellular Vesicles (ISEV), the leading international advocate and guide of research on extracellular vesicles ( ... […]
- International Society for Extracellular Vesicles Releases Latest Study to the Members of the EV Field on November 26, 2018 at 4:00 pm
The International Society for Extracellular Vesicles (ISEV), the leading international advocate and guide of research on extracellular vesicles (EVs), is pleased to announce the publication of this ye... […]
- Diagnostic Exosome Biomarkers Market Forecast By End-use Industry 2017 - 2027 on November 26, 2018 at 4:43 am
The fusion of plasma membrane with the internal vesicle fusion leads to the secretion of nanovescicles called exosomes into the extracellular environment. The fusion of plasma membrane with the intern... […]
- A Trojan horse delivery method for miRNA-enriched extracellular vesicles on November 20, 2018 at 3:31 pm
A method for large-scale production of extracellular vesicles enriched with specific microRNAs (miRNAs) has been developed, offering a manufacturing standardization process which may have therapeutic ... […]
- A Trojan horse delivery method for miRNA-enriched extracellular vesicles on November 20, 2018 at 1:14 pm
A method for large-scale production of extracellular vesicles enriched with specific microRNAs (miRNAs) has been developed in the Wake Forest Institute for Regenerative Medicine (WFIRM) labs, offering ... […]
- Journal Highlight: Proteomic analysis of extracellular vesicles for cancer diagnostics on November 19, 2018 at 1:39 am
Abstract: Extracellular vesicles (EVs) including exosomes and microvesicles are lipid bilayer‐encapsulated nanoparticles released by cells, ranging from 40 nm to several microns in diameter. Biologica... […]
- Esperite Group with The Cell Factory, expands its patent portfolio on extra-cellular vesicles biologic drugs in Canada. on November 6, 2018 at 10:21 pm
Esperite`s (ESP.NX) biotech company The Cell Factory has obtained the patent for the use of extracellular vesicles (EVs) in the treatment of acute and chronic inflammatory and autoimmune diseases in C... […]
- Extracellular vesicles help pass information between cells and onto offspring on November 5, 2018 at 2:08 pm
New studies reveal that small, membrane-bound particles transported between cells have wide-ranging and long-term effects in the brain and throughout the body, from helping neurons communicate to pass... […]
via Bing News